for you to [89:10%: Cardiovascular: Hypertension (40%; grades 3/4: 16%) Central nervous system: Fatigue (39%), voice disorder (31%), headache (14%) Dermatologic: Palmar-plantar erythrodysesthesia (27%; grades 3/4: 5%), skin rash (13%; grades 3/4:] Drug Status Rx Availability Prescription only D Pregnancy Category Positive evidence of risk N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Axitinib Rating No Reviews - Be the first! 6.0 /10 No Reviews - Be the first! 6.0 Rate it! Drug Class Multikinase inhibitors VEGF / VEGFR inhibitors Related Drugs multikinase inhibitors Imbruvica , Nexavar , Jakafi , Sutent , ibrutinib , Stivarga VEGF / VEGFR inhibitors Avastin , Nexavar , Sutent , bevacizumab , Votrient , Stivarga Renal Cell Carcinoma Avastin , Opdivo , nivolumab , Nexavar , Afinitor , Sutent , bevacizumab , Votrient , sorafenib , everolimus , pazopanib , Lenvima , Cabometyx , sunitinib , Proleukin , lenvatinib , Inlyta , cabozantinib , Torisel , temsirolimus , aldesleukin , More... a chosen
the masses Axitinib pictures
EmoticonEmoticon